Structure Therapeutics Statistics
NASDAQ: GPCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
16.13-0.99 (-5.78%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Structure Therapeutics by the numbers
Structure Therapeutics has a market capitalization of $1.15 billion based on 71.59M shares outstanding. With trailing EPS of $-3.90, Structure Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 36.7% below its 50-day average and 63.3% below its 200-day average.
Average daily trading volume is 1.18M shares, or about $19.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GPCR valuation vs. peer median
| Metric | GPCR | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.15B | $1.18B | -3% |
| Avg. volume | 1.18M | 1.09M | +8% |
Peer median across 8 companies: OPK, HROW, CMPS, AAPG, GHRS, AMPH, MLYS, OCUL.
Valuation
- Market cap
- $1.15B
- EPS (TTM)
- $-3.90
- Shares outstanding
- 71.59M
Price and trading
- Previous close
- 17.12
- Open
- 16.73
- Day range
- 16.08 – 17.08
- 52-week range
- 16.06 – 94.90
- 52-week change
- -53.00%
- Beta
- —
- Volume
- 786.13K
- Average volume
- 1.18M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 1.15B
- Forward Pe
- -6.45
- Eps
- -3.90
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 94.90
- Week52 Low
- 16.06
- Avg Volume
- 1.18M
- Shares Outstanding
- 71.59M
- Ma50
- 25.49
- Ma200
- 43.96
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -83.00%
- Pct From52w Low
- 0.44%